Literature DB >> 1534309

Antigen-presentation by macrophages but not by dendritic cells in human immunodeficiency virus (HIV) infection.

S E Macatonia1, M Gompels, A J Pinching, S Patterson, S C Knight.   

Abstract

Dendritic cells (DC) have a potent antigen-presenting capacity for recruiting resting T cells into immune responses. They also promote expansion of already activated memory T cells. By contrast, macrophages (M phi) are only effective in stimulating memory responses. Infection and depletion of DC occur in human immunodeficiency virus (HIV)-infected individuals and recruitment of T cells into primary responses is blocked. Here comparisons between DC and M phi in stimulating secondary T-cell responses in HIV infection were made. Adherent M phi, and DC isolated by a new method, were separated from peripheral blood of patients in different stages of HIV infection and from uninfected controls and added to allogeneic lymphocytes in mixed leucocyte reactions (MLR). Some were pulsed with influenza virus or tetanus toxoid and used to stimulate autologous T cells. Responses were measured from uptake of [3H]thymidine in 20 microliters hanging drop cultures. DC, but not M phi, from normal individuals stimulated MLR but both populations stimulated secondary responses to recall antigens. DC from all HIV seropositive individuals caused little or no stimulation of any lymphocyte responses. However, M phi from HIV seropositive asymptomatic individuals and those with persistent generalized lymphadenopathy stimulated responses to recall antigens. There was no stimulation using cells from acquired immune deficiency syndrome (AIDS) patients. Blocked DC but not M phi function may underlie progressive immunological non-responsiveness in HIV infection. Without recruitment of resting T cells, loss of memory T cells may be cumulative; failure of secondary activation (e.g. by M phi) would lead to lost T-cell activity. Identification and circumvention of the defect in DC could offer new therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534309      PMCID: PMC1384833     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  The human immunodeficiency virus long terminal repeat is preferentially expressed in Langerhans cells in transgenic mice.

Authors:  J Leonard; J S Khillan; H E Gendelman; A Adachi; S Lorenzo; H Westphal; M A Martin; M S Meltzer
Journal:  AIDS Res Hum Retroviruses       Date:  1989-08       Impact factor: 2.205

Review 2.  The immunopathogenesis of HIV infection.

Authors:  Z F Rosenberg; A S Fauci
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

3.  Infection of human epidermal Langerhans' cells by HIV.

Authors:  J Kanitakis; J Thivolet
Journal:  AIDS       Date:  1990-03       Impact factor: 4.177

Review 4.  Langerhans cells: role in contact hypersensitivity and relationship to lymphoid dendritic cells and to macrophages.

Authors:  I Silberberg-Sinakin; I Gigli; R L Baer; G J Thorbecke
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

5.  Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men.

Authors:  C J van Noesel; R A Gruters; F G Terpstra; P T Schellekens; R A van Lier; F Miedema
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

Review 6.  HIV I infection of dendritic cells.

Authors:  S C Knight; S E Macatonia; S Patterson
Journal:  Int Rev Immunol       Date:  1990       Impact factor: 5.311

Review 7.  Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection.

Authors:  M S Meltzer; D R Skillman; P J Gomatos; D C Kalter; H E Gendelman
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

8.  Dendritic cell infection, depletion and dysfunction in HIV-infected individuals.

Authors:  S E Macatonia; R Lau; S Patterson; A J Pinching; S C Knight
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

9.  The detection of human immunodeficiency virus DNA in dendritic cells from the joints of patients with aseptic arthritis.

Authors:  R A Hughes; S E Macatonia; I F Rowe; A C Keat; S C Knight
Journal:  Br J Rheumatol       Date:  1990-06

Review 10.  Defective signal transduction--a common pathway for cellular dysfunction in HIV infection?

Authors:  A J Pinching; K E Nye
Journal:  Immunol Today       Date:  1990-07
View more
  24 in total

1.  Varicella-zoster virus productively infects mature dendritic cells and alters their immune function.

Authors:  Gavin Morrow; Barry Slobedman; Anthony L Cunningham; Allison Abendroth
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 2.  HIV-1 and the hijacking of dendritic cells: a tug of war.

Authors:  Marie Larsson
Journal:  Springer Semin Immunopathol       Date:  2005-01

3.  Increase in dendritic cell numbers, their function and the proportion uninfected during AZT therapy.

Authors:  M Gompels; S Patterson; M S Roberts; S E Macatonia; A J Pinching; S C Knight
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

Review 4.  Molecular immunopathogenesis of HIV infection.

Authors:  T T Ng; A J Pinching; C Guntermann; W J Morrow
Journal:  Genitourin Med       Date:  1996-12

Review 5.  Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection.

Authors:  D Weissman; A S Fauci
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

6.  Modulation of T cell responses to recall antigens presented by Langerhans cells in HIV-discordant identical twins by anti-interleukin (IL)-10 antibodies and IL-12.

Authors:  A Blauvelt; C Chougnet; G M Shearer; S I Katz
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

7.  Impaired accessory cell function in a human dendritic cell line after human immunodeficiency virus infection.

Authors:  Prarthana Beuria; Houchu Chen; Michael Timoney; Kirk Sperber
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

8.  Dendritic cells infected in vitro with human T cell leukaemia/lymphoma virus type-1 (HTLV-1); enhanced lymphocytic proliferation and tropical spastic paraparesis.

Authors:  A Ali; S Patterson; K Cruickshank; P Rudge; A G Dalgleish; S C Knight
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

9.  Impact on genetic networks in human macrophages by a CCR5 strain of human immunodeficiency virus type 1.

Authors:  Carter R Coberley; James J Kohler; Joseph N Brown; Joseph T Oshier; Henry V Baker; Michael P Popp; John W Sleasman; Maureen M Goodenow
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

10.  Differentiation and immune function of human dendritic cells following infection by respiratory syncytial virus.

Authors:  A Jones; I Morton; L Hobson; G S Evans; M L Everard
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.